What is the ticker symbol for MiNK Therapeutics?

MiNK Therapeutics trades under the ticker INKT on NASDAQ.

What sector does MiNK Therapeutics operate in?

MiNK Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze INKT in a portfolio?

PortView shows INKT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

MiNK Therapeutics (INKT) Stock Analysis

NASDAQHealthcareBiotechnology

$10.94+2.92%

1-year price historyRange $8.56 – $14.21

52-week range$10.94

$8.48$16.93

Track INKT in your portfolio for free · Portfolio tracker

What MiNK Therapeutics does

MiNK Therapeutics, Inc. is a biopharmaceutical firm currently undergoing clinical trials. Its primary focus is on the identification, advancement, and market introduction of innovative invariant natural killer T (iNKT) cell therapies. These treatments are allogeneic and designed to be "off-the-shelf," providing readily available options for combating various cancers and conditions rooted in immune system dysfunction. The company's leading investigational therapy is AGENT-797. This product is an allogeneic, ready-to-use iNKT cell therapy, presently in Phase 1 clinical studies to assess its effectiveness against different forms of myeloma. Established in 2017, the company was previously known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. is headquartered in New York, New York, and operates as a subsidiary of Agenus Inc.

Key metrics

Market cap

$55.83M

P/E (TTM)

-4.64

EPS (TTM)

$-2.36

Beta

0.47

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$11.40

200-day avg

$11.31

52-week high

$16.93

52-week low

$8.48

CEO

Jennifer S. Buell

ETFs linked to INKT

Broad-market and Healthcare sector ETFs an investor holding MiNK Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how INKT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze INKT in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for MiNK Therapeutics?: MiNK Therapeutics trades under the ticker INKT on NASDAQ.
Which exchange is INKT listed on?: INKT is listed on NASDAQ.
What sector does MiNK Therapeutics operate in?: MiNK Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze INKT in a portfolio?: PortView shows INKT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.